Skip to main content
. 2022 Jan 11;6(1):281–292. doi: 10.1182/bloodadvances.2021005628

Figure 3.

Figure 3.

Survival. (A) Overall survival (OS) and transplant-related mortality (TRM) of the whole cohort. (B) Event-free survival of the whole cohort. (C) Disease-free survival of the whole cohort (excluding 2 patients with ALD, who had CNS involvement at the time of HSCT). (D) OS according to infectious status at transplant (ie, active or recent infection at the time of HSCT versus no infection).